MG
RCKT icon

Marex Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Marex Group’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Hold
72,500
– – ﹤0.01% 932
2026
Q1 		$260K Buy
72,500
+15,000
+26% +$59.6K ﹤0.01% 820
2025
Q4 		$202K Buy
57,500
+29,000
+102% +$99.3K ﹤0.01% 847
2025
Q3 		$92.9K Buy
28,500
+6,000
+27% +$18.9K ﹤0.01% 780
2025
Q2 		$55.1K Hold
22,500
– – ﹤0.01% 592
2025
Q1 		$150K Buy
22,500
+5,000
+29% +$49.4K ﹤0.01% 600
2024
Q4 		$220K Buy
+17,500
New +$263K ﹤0.01% 522

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Marex Group's RCKT Position: Q2 2026 in Review

Marex Group held its Rocket Pharmaceuticals (RCKT) position steady in Q2 2026 at 72,500 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #932.

Marex Group first reported a position in RCKT in Q4 2024 and has held it in 7 quarters since. The position peaked at $260K in Q1 2026. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Marex Group held 72,500 shares of Rocket Pharmaceuticals worth $248K as of Q2 2026.
  • Marex Group left its Rocket Pharmaceuticals share count unchanged in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of Marex Group's portfolio in Q2 2026, its #932 holding.
  • Marex Group first reported a position in Rocket Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Marex Group's Rocket Pharmaceuticals position peaked at $260K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.